DCVC Opportunity Fund II GP, LLC

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Reported portfolio value by quarter (15 quarters reported)

$200M $13.9M

Q4 21 Q3 22 Q2 24 Q1 25 Q4 25 Q2 26

$200M in Q4 2021 → $17.2M now. Hover for any quarter.

Holdings

As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.

Holding	% of portfolio	Activity	Shares	Value
Recursion Pharmaceuticals, Inc.	84.3%	Unchanged	3,951,141	$14.5M
Ionq, Inc.	15.7%	Trimmed 16%	50,705	$2.7M

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

quarter ended June 30, 2026 · filed August 14, 2026

Company	Action	Shares changed	Value of change	% of portfolio
Ionq, Inc.	Trimmed	−9,521	−$507K	15.7%

quarter ended March 31, 2026 · filed May 15, 2026

Company	Action	Shares changed	Value of change	% of portfolio
Ionq, Inc.	Added	+50,705	+$1.46M	12.5%

quarter ended December 31, 2025 · filed February 17, 2026

Company	Action	Shares changed	Value of change	% of portfolio
Ionq, Inc.	New	+9,521	+$427K	2.6%

quarter ended September 30, 2025 · filed November 14, 2025

Company	Action	Shares changed	Value of change	% of portfolio
Rocket Lab Corp	Exited	−2,663,139	−$95.3M	—

quarter ended June 30, 2025 · filed August 14, 2025

Company	Action	Shares changed	Value of change	% of portfolio
Rocket Lab Corp	New	+2,663,139	+$95.3M	82.7%
RL Rocket Lab Usa, Inc.	Exited	−3,388,249	−$60.6M	—

quarter ended March 31, 2025 · filed May 15, 2025

No position changes this quarter.

quarter ended December 31, 2024 · filed February 14, 2025

Company	Action	Shares changed	Value of change	% of portfolio
RL Rocket Lab Usa, Inc.	Trimmed	−3,814,786	−$97.2M	76.4%
Rigetti Computing, Inc.	Exited	−1,599,052	−$1.25M	—

quarter ended September 30, 2024 · filed November 14, 2024

No position changes this quarter.

Comments